Received May 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
HCP called to report a patient received an expired dose of GARDASIL 9. The product expired 02/14/2025 and was administered to one patient 04/28/2025. No side effects or symptoms have been reported, and product had not undergone a temperature excursio; HCP called to report a patient received an expired dose of GARDASIL 9. The product expired 02/14/2025 and was administered to one patient 04/28/2025. No side effects or symptoms have been reported, and product had not undergone a temperature excursio; This spontaneous report was received from a physician concerning a 12-year-old female patient. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 28-APR-2025, the patient was vaccinated with an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) ( lot number not reported, expiration date: 14-FEB-2025) 0.5 mL (0.5ml), (lot # was not reported) as prophylaxis. No side effects or symptoms have been reported and product had not undergone a temperature excursion. No additional information provided. The operator of device was health professional. Lot # is being requested and will be submitted if received.